BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23717480)

  • 1. Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporter.
    Heitland I; Groenink L; Bijlsma EY; Oosting RS; Baas JM
    PLoS One; 2013; 8(5):e63772. PubMed ID: 23717480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human fear acquisition deficits in relation to genetic variants of the corticotropin-releasing hormone receptor 1 and the serotonin transporter--revisited.
    Heitland I; Groenink L; van Gool JM; Domschke K; Reif A; Baas JM
    Genes Brain Behav; 2016 Feb; 15(2):209-20. PubMed ID: 26643280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cue learning, trait anxiety and genetic variation in the serotonin 1A receptor on contextual fear.
    Baas JM; Heitland I
    Int J Psychophysiol; 2015 Dec; 98(3 Pt 2):506-14. PubMed ID: 25448266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing.
    Weber H; Richter J; Straube B; Lueken U; Domschke K; Schartner C; Klauke B; Baumann C; Pané-Farré C; Jacob CP; Scholz CJ; Zwanzger P; Lang T; Fehm L; Jansen A; Konrad C; Fydrich T; Wittmann A; Pfleiderer B; Ströhle A; Gerlach AL; Alpers GW; Arolt V; Pauli P; Wittchen HU; Kent L; Hamm A; Kircher T; Deckert J; Reif A
    Mol Psychiatry; 2016 Jun; 21(6):813-22. PubMed ID: 26324098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifelong disturbance of serotonin transporter functioning results in fear learning deficits: Reversal by blockade of CRF1 receptors.
    Bijlsma EY; Hendriksen H; Baas JM; Millan MJ; Groenink L
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1733-43. PubMed ID: 26302762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in serotonin transporter function affects human fear expression indexed by fear-potentiated startle.
    Klumpers F; Heitland I; Oosting RS; Kenemans JL; Baas JM
    Biol Psychol; 2012 Feb; 89(2):277-82. PubMed ID: 22061270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder.
    Lonsdorf TB; Weike AI; Nikamo P; Schalling M; Hamm AO; Ohman A
    Psychol Sci; 2009 Feb; 20(2):198-206. PubMed ID: 19175757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms, genes and treatment: Experimental fear conditioning, the serotonin transporter gene, and the outcome of a highly standardized exposure-based fear treatment.
    Wannemueller A; Moser D; Kumsta R; Jöhren HP; Adolph D; Margraf J
    Behav Res Ther; 2018 Aug; 107():117-126. PubMed ID: 29960126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1.
    Heitland I; Klumpers F; Oosting RS; Evers DJ; Leon Kenemans J; Baas JM
    Transl Psychiatry; 2012 Sep; 2(9):e162. PubMed ID: 23010766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contextual fear conditioning in virtual reality is affected by 5HTTLPR and NPSR1 polymorphisms: effects on fear-potentiated startle.
    Glotzbach-Schoon E; Andreatta M; Reif A; Ewald H; Tröger C; Baumann C; Deckert J; Mühlberger A; Pauli P
    Front Behav Neurosci; 2013; 7():31. PubMed ID: 23630477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human fear reconsolidation and allelic differences in serotonergic and dopaminergic genes.
    Agren T; Furmark T; Eriksson E; Fredrikson M
    Transl Psychiatry; 2012 Feb; 2(2):e76. PubMed ID: 22832813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone.
    de Jongh R; Groenink L; van der Gugten J; Olivier B
    Biol Psychiatry; 2003 Nov; 54(10):1041-8. PubMed ID: 14625146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactive effects of corticotropin releasing hormone receptor 1, serotonin transporter linked polymorphic region, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology.
    Cicchetti D; Rogosch FA; Oshri A
    Dev Psychopathol; 2011 Nov; 23(4):1125-38. PubMed ID: 22018085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitizing effect of early adversity on depressive reactions to later proximal stress: Moderation by polymorphisms in serotonin transporter and corticotropin releasing hormone receptor genes in a 20-year longitudinal study.
    Starr LR; Hammen C; Conway CC; Raposa E; Brennan PA
    Dev Psychopathol; 2014 Nov; 26(4 Pt 2):1241-54. PubMed ID: 25422958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorsomedial Prefrontal Cortex Mediates the Impact of Serotonin Transporter Linked Polymorphic Region Genotype on Anticipatory Threat Reactions.
    Klumpers F; Kroes MC; Heitland I; Everaerd D; Akkermans SE; Oosting RS; van Wingen G; Franke B; Kenemans JL; Fernández G; Baas JM
    Biol Psychiatry; 2015 Oct; 78(8):582-9. PubMed ID: 25444169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactive effects of corticotropin-releasing hormone receptor 1 gene and work stress on burnout in medical professionals in a Chinese Han population.
    He SC; Wu S; Du XD; Jia Q; Wang C; Wu F; Ning Y; Wang D; Wang L; Zhang XY
    J Affect Disord; 2019 Jun; 252():1-8. PubMed ID: 30953926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to condition to a cue is associated with sustained contextual fear.
    Baas JM; van Ooijen L; Goudriaan A; Kenemans JL
    Acta Psychol (Amst); 2008 Mar; 127(3):581-92. PubMed ID: 18048004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety.
    Armbruster D; Moser DA; Strobel A; Hensch T; Kirschbaum C; Lesch KP; Brocke B
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):393-401. PubMed ID: 18925984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients.
    Jovanovic T; Duncan EJ; Kaye J; Garza K; Norrholm SD; Inslicht SS; Neylan TC; Mathew SJ; Iosifescu D; Rothbaum BO; Mayberg HS; Dunlop BW
    Psychophysiology; 2020 Jan; 57(1):e13356. PubMed ID: 30807663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.